FOURTH CONFERENCE OF SOCIETY OF TOXICOLOGIC PATHOLOGY - INDIA “CONTINUING EDUCATION IN TOXICOLOGIC PATHOLOGY – RESPIRATORY AND CARDIOVASCULAR SYSTEM” ORGANIZED BY: SOCIETY OF TOXICOLOGIC PATHOLOGY - INDIA (STP-I) NOVEMBER 1-3, 2012 VENUE: “Chancery” The Atria Hotel # 1, Palace Road, Bangalore - 560 001 Society of Toxicologic Pathology - India 29, 1 st cross, Malleshwaram, Bangalore - 560 003, Karnataka, India e-mail: [email protected], Website: http://www.toxpathindia.com 1
16
Embed
FOURTH CONFERENCE OF SOCIETY OF … program fourth STPI...fourth conference of society of toxicologic pathology - india “continuing education in toxicologic pathology – respiratory
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
FOURTH CONFERENCE OF
SOCIETY OF TOXICOLOGIC PATHOLOGY -
INDIA
“CONTINUING EDUCATION IN TOXICOLOGIC
PATHOLOGY – RESPIRATORY AND CARDIOVASCULAR
SYSTEM”
ORGANIZED BY:
SOCIETY OF TOXICOLOGIC PATHOLOGY - INDIA (STP-I)
NOVEMBER 1-3, 2012
VENUE: “Chancery” The Atria Hotel
# 1, Palace Road, Bangalore - 560 001
Society of Toxicologic Pathology - India 29, 1st cross, Malleshwaram, Bangalore - 560 003, Karnataka, India
In Australia, I have held the positions of Development Director at Antisense Therapeutics Ltd and for the last 6 years as Director, Drug Safety at Biota Holdings Ltd in Melbourne, which is a publicly listed company developing anti-viral agents for respiratory and liver infections.
Kevin Isaacs MA, Vet MB, MRCVS, FRCPath
Consultant Toxicologic Pathologist, UK
Kevin Isaacs is a graduate of the Cambridge Veterinary School, having first gained a 1st in Part I of the Tripos exams before completing Part II in Social & Political Sciences. In 1983 he passed the examinations for membership of the Royal College of Pathologists in Laboratory Animal Pathology. After a two-year spell as a small animal veterinarian, he started life as a toxicological pathologist at Huntingdon Research Centre in 1978. His career developed through positions at ICI Pharmaceuticals, ICI Central Toxicology Laboratory, Smith Kline & French and Experimental Pathology Laboratories (UK), which he ran as Director for 5 years, before becoming an independent consultant in 1994.
Kevin has been President, Chair of the Education sub-committee and webmaster of the British Society for Toxicological Pathology; President and webmaster of the British Society of Veterinary Pathology; Chair of the Specialty Advisory Committee for Veterinary Pathology and Examiner for the Royal College of Pathologists and Chair of the Veterinary Pathology Liaison Group for the Royal College of Veterinary Surgeons. He has spoken at numerous meetings for the BSTP and in various other international meetings over the years.
Madhav R. Marathe
M.V.Sc (Veterinary Pathology), FIBA (UK), cGLP (USA).
Vice President, Toxicology and Animal House. Sun Pharma Advanced Research Company Ltd, Vadodara (Gujarat),
Senior most Pre-clinical Toxicologist and Pathologist in India, in New Drug Discovery Research, with 40 year‟s experience. B. V. Sc with Honours (1965) and M.V. Sc in Pathology with distinction from Bombay University, Mumabi (1970). Recipient of “Outstanding Scientist of 21st Century Award” with a “Medal of Honour” from Cambridge, England (2007). Diplomate of Indian Board of Toxicologic Pathology (2011). Certification of “Good Laboratory Practice & Quality Assurance” USA (1996). Served as Toxicologist and Pathologist in CIBA-GEIGY, Ranbaxy, Lupin and presently with Sun-Pharma, Vadodara as Vice President (Toxicology and Laboratory Animal Resources). Built “AAALAC” accredited modern Animal house in Sun Pharma (2009). Principal Investigator of Toxicology Studies carried out in USA, UK, Switzerland, Germany, France and Czech Republic. Submitted > 1000 Toxicology studies to US FDA on “First Time Right” basis. Guide to Ph.D. students in Zoology/Toxicology and faculty member in M.S. University, Baroda.
12
Speaker’s Profile
Shashi Ramaiah, PhD, DACVP
Precision Medicine lead and head of Clinical Pathology and Safety Biomarker group, Pfizer Pharmaceuticals, Cambridge, MA E mail: [email protected]
Shashi Ramaiah is currently the Precision Medicine lead and head of Clinical Pathology and Safety Biomarker group within Pfizer Inc. Cambridge, MA. Shashi‟s responsibilities as biomarker head includes scientific leadership and supervision of laboratory operations & personnel aimed at developing innovative and efficient biomarker strategies and providing routine clinical pathology analyses to support animal models evaluations. Additional responsibilities include representing drug safety on project teams, relevant project & issues management teams to provide scientific guidance on biomarker strategies. Precision medicine lead responsibilities include representing project teams from lead selection to POC to ensure translational/precision medicine biomarker strategies are developed through partnerships in discovery, clinical and partner lines.
Shashi Ramaiah‟s early education was in India where he completed his Veterinary Medicine degree (BVSc) from the University of Agricultural Sciences, Bangalore, India and then completed Masters in Pharmacology and Toxicology (MVSc) from the same University. After couple of years of small animal medicine practice, Shashi migrated to USA in 1995 and completed his PhD (1999) from University of Louisiana at Monroe in Pharmacology and Toxicology. After completing his PhD, Shashi enrolled in the Clinical Pathology residency program at University of Florida (1999-2002) and completed his certification in Veterinary Clinical Pathology in 2002. Following his residency training, Shashi accepted a tenure track faculty position in the department of Veterinary Pathobiology, College of Veterinary Medicine at Texas A&M University. During his ~6 yr stint as a faculty at Texas A&M, Shashi pursued his independent research on an NIH-NIAAA funded research grant on alcoholic hepatitis and non alcoholic fatty liver syndrome. In addition to his research, Shashi participated in diagnostic clinical pathology service, residency training and graduate student teaching at Texas A&M University. In 2008, Shashi made a career change from academia to Pfizer pharmaceutical industry.
Shashi is on the editorial boards of Toxicologic Pathology, International Journal of Toxicology and Veterinary Clinical Pathology journals. Shashi previously served as the secretary of Gulf Coast and Central States regional chapter of the Society of Toxicology and as the Chair of the Continuing Education committee for Society of Toxicologic Pathology. Shashi has published in the areas of toxicology, clinical pathology and biomarkers (>40 peer reviewed manuscripts) and has chaired numerous scientific symposium and workshops at toxicology and pathology meetings. Shashi is also an active member of the Society of Toxicology, American College of Veterinary Pathology and Society of Toxicologic Pathology. Shashi is an adjunct faculty at the College of Veterinary Medicine in Michigan State University and Texas A&M University. As an adjunct faculty at Michigan State University, Shashi serves as a mentor for one of the Pfizer-sponsored ACVP-STP coalition fellows.
13
Speaker’s Profile
Pierre Tellier, D.V.M., Dip.Path., M.Sc., Diplomate ACVP
Registration fee Before October 1 Spot registration fee
STP-I member Rs. 4000 Rs. 4500
Non member Rs. 5000 Rs. 5500
Students Rs. 2500
Online transfer details: Axis Bank Ltd, Electronic City, A/C name: Society of Toxicologic Pathology – India, A/C # 912010024584538, IFS Code: UTIB0000677. Intimation of online transfer with filled registration form e-mailed to [email protected] At par cheque/draft to be drawn in favour of Society of Toxicologic Pathology - India (STP-I), payable at Bangalore sent to Dr. Shekar Chelur, Aurigene Discovery Technologies Ltd. 39-40, KIADB Industrial Area, Electronics City Phase II, Hosur Road, Bangalore - 560 100, Phone (O): 080-28521314, Mobile: +91 98802 37237